Carbon monoxide ameliorates murine T-cell-dependent colitis through the inhibition of Th17 differentiation

Tomohisa Takagi, Yuji Naito, Makoto Tanaka, Katsura Mizushima, Chihiro Ushiroda, Yuki Toyokawa, Kazuhiko Uchiyama, Masahide Hamaguchi, Osamu Handa, Yoshito Itoh

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

Recent studies have identified carbon monoxide (CO) as a potential therapeutic molecule for the treatment of inflammatory diseases including intestinal inflammation. In the present study, we explored the efficacy and the mechanisms of action of CO-releasing molecule (CORM)-A1 in T-cell transfer induced colitis model in mice. In addition, the impact of CORM-A1 on the T helper (Th) cell differentiation was evaluated using naïve CD4 + T cells isolated from the spleens in Balb/c mice. The results showed that CORM-A1 conferred protection against the development of intestinal inflammation and attenuated Th17 cell differentiation. Hence, the observed immunomodulatory effects of CORM-A1 could be useful for developing novel therapeutic approaches for managing intestinal inflammation through the regulation of Th17 differentiation.

Original languageEnglish
Pages (from-to)1328-1335
Number of pages8
JournalFree Radical Research
Volume52
Issue number11-12
DOIs
Publication statusPublished - 02-12-2018
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Biochemistry

Fingerprint

Dive into the research topics of 'Carbon monoxide ameliorates murine T-cell-dependent colitis through the inhibition of Th17 differentiation'. Together they form a unique fingerprint.

Cite this